Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling.
Xu J, Sun S, Zhang W, Dong J, Huang C, Wang X, Jia M, Yang H, Wang Y, Jiang Y, Cao L, Huang Z.
Xu J, et al. Among authors: sun s.
Front Pharmacol. 2022 Nov 30;13:1027577. doi: 10.3389/fphar.2022.1027577. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36532767
Free PMC article.